ProMIS Neurosciences Closes $7.2 Million Private Placement

TORONTO and CAMBRIDGE, MA, May 1, 2018 -- (Healthcare Sales & Marketing Network) - ProMIS Neurosciences Inc. (TSX:PMN; OTCQB:ARFXF) is pleased to announce that it closed yesterday a private placement of 19,306,668 Units at the price of CDN$0.375 per Unit ... Biopharmaceuticals, Neurology, Venture Capital ProMIS Neurosciences, Alzheimer's disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news